HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
13.78
-0.07 (-0.51%)
At close: Mar 9, 2026, 4:00 PM EDT
13.77
-0.01 (-0.07%)
After-hours: Mar 9, 2026, 4:10 PM EDT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.44 billion as of March 9, 2026. Its market cap has decreased by -8.61% in one year.
Market Cap
2.44B
Enterprise Value
1.19B
1-Year Change
-8.61%
Ranking
Category
Stock Price
$13.78
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.44B, an increase of 52.87%. That is a compound annual growth rate of 4.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.42B | 3.93% |
| Dec 31, 2025 | 2.33B | -7.42% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 3.59B |
| Kiniksa Pharmaceuticals International, | 3.53B |
| Prestige Consumer Healthcare | 3.18B |
| Liquidia | 3.17B |
| Supernus Pharmaceuticals | 3.10B |
| BioCryst Pharmaceuticals | 2.13B |
| Bausch Health Companies | 1.99B |
| Phibro Animal Health | 1.94B |